Table 2 Effect of the intervention on primary outcome and maternal process-of-care outcomes
Intervention period (N = 14,814 women) | Control period (N = 11,517 women) | RR (95% CI)e | |||
|---|---|---|---|---|---|
n/N | (%) | n/N | (%) | ||
Primary outcome | |||||
Cesarean section in Robson Group 1 | 1,709/4,302 | (39.7) | 1,602/3,543 | (45.2) | 0.85 (0.54–1.33) |
Maternal process-of-care outcomes | |||||
Cesarean section in women in Robson Groups 1 and 3 | 2,012/7,485 | (26.9) | 1,919/6,204 | (30.9) | 0.81 (0.59–1.11) |
Cesarean section in women in Robson Groups 1, 2, 3, 4 and 5 | 6,529/12,735 | (51.3) | 5,028/9,808 | (51.3) | 0.92 (0.78–1.10) |
Cesarean section (all women) | 7,505/14,814 | (50.7) | 5,817/11,517 | (50.5) | 0.91 (0.71–1.15) |
Augmentation with oxytocin during labora | 912/9,764 | (9.3) | 2,273/8,318 | (27.3) | 0.34 (0.01–15.04) |
Artificial rupture of the membranesa,d | 553/9,764 | (5.7) | 559/8,318 | (6.7) | - |
Episiotomyb | 4,820/7,309 | (65.9) | 3,137/5,700 | (55.0) | 0.99 (0.73–1.35) |
Operative vaginal birthb | 192/7,309 | (2.63) | 112/5,700 | (1.96) | 1.12 (0.13–9.36) |
Days from admission to childbirthc | 0.34 | (0.73) | 0.30 | (0.68) | 0.05 (−0.31–0.41) |
Days from childbirth to dischargec | 3.29 | (1.75) | 3.52 | (1.88) | 0.23 (−0.84–1.30) |